Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Divis Labs, including ...
Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...
Reported Consolidated quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,604.00 crore in December 2025 up 12.29% ...
Earnings call Divi’s Laboratories reported strong Q2 FY25 results with consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose 46.6% YoY to ₹510 crore. Growth was led ...
NDTV Profit on MSN
Stock picks today: Reliance Industries, Adani Ports, Divis Labs, Uno Minda and more on brokerages' radar
Brokerages including Morgan Stanley, Jefferies, Macquarie and Goldman Sachs have issued fresh views on Reliance Industries, Adani Ports, Divis Labs, Uno Minda and Dixon Technologies.
HYDERABAD, India--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active ...
Stock market today: Indian equity indices remained largely unchanged on Wednesday as financial stocks retraced from their near-record peaks, counterbalancing the positive sentiment surrounding a ...
Divi's Laboratories proposes ₹30 per share final dividend for FY25 Stock price reaches record ₹6,764, up 4.37 percent New long-term pharma supply deal triggers ₹650-750 crore investment Shares of ...
Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of ...
Earnings call Divi's Laboratories reported a 17% YoY revenue growth in Q2 FY26, driven by a record 56% contribution from custom synthesis. Margins remained resilient despite ongoing generic pricing ...
Reported Standalone quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,578.00 crore in December 2025 up 12.23% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results